Entera Bio Ltd
NASDAQ:ENTX
Entera Bio Ltd
Net Change in Cash
Entera Bio Ltd
Net Change in Cash Peer Comparison
Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors
Company | Net Change in Cash | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Entera Bio Ltd
NASDAQ:ENTX
|
Net Change in Cash
-$1.3m
|
CAGR 3-Years
42%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
|
Collplant Biotechnologies Ltd
NASDAQ:CLGN
|
Net Change in Cash
-$3.2m
|
CAGR 3-Years
-94%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Kamada Ltd
NASDAQ:KMDA
|
Net Change in Cash
$21.4m
|
CAGR 3-Years
21%
|
CAGR 5-Years
36%
|
CAGR 10-Years
7%
|
|
B
|
BioLine RX Ltd
TASE:BLRX
|
Net Change in Cash
-$6.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-30%
|
CAGR 10-Years
5%
|
Urogen Pharma Ltd
NASDAQ:URGN
|
Net Change in Cash
$94.9m
|
CAGR 3-Years
89%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
B
|
Bonus Biogroup Ltd
TASE:BONS
|
Net Change in Cash
-₪40.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Entera Bio Ltd's Net Change in Cash?
Net Change in Cash
-1.3m
USD
Based on the financial report for Dec 31, 2023, Entera Bio Ltd's Net Change in Cash amounts to -1.3m USD.
What is Entera Bio Ltd's Net Change in Cash growth rate?
Net Change in Cash CAGR 5Y
21%
Over the last year, the Net Change in Cash growth was 90%. The average annual Net Change in Cash growth rates for Entera Bio Ltd have been 42% over the past three years , 21% over the past five years .